The Effects of Simvastatin on Free Fatty Acids Profile in Fructose-fed Insulin Resistant Rats

Document Type : Original Article


1 Department of Internal Medicine, Afzalipour School of Medicine, Kerman University of Medical Sciences, Kerman, Iran

2 Professor, Physiology Research Center & Department of Clinical Biochemistry, Afzalipour School of Medicine, Kerman University of Medical Sciences, Kerman, Iran

3 Associate Professor, Department of Clinical Biochemistry, Afzalipour School of Medicine, Kerman University of Medical Sciences, Kerman, Iran

4 Department of Clinical Biochemistry, Afzalipour School of Medicine, Kerman University of Medical Sciences, Kerman, Iran


Backgrounds: Type 2 diabetes mellitus is the most common metabolic disease and free fatty acids, as signaling molecules, can play a crucial role in the development of it. Different free fatty acids, through various cell membrane receptors, induce different effects on metabolic pathways and thereby affect insulin sensitivity. Simvastatin is a cholesterol decreasing drug prescribed for hypercholesterolemic patients. Due to the observing insulin-sensitizing effect of simvastatin in our previous study, we decided to evaluate its effects on free fatty acids profile as a probable mechanism for alteration of insulin sensitivity.
Methods: Insulin resistance was developed in male Wistar rats by a high fructose diet for 6 weeks. After this period, animals were treated by intragastric injection of simvastatin for two weeks. Blood samples were collected in EDTA treated tubes and plasma was separated. After isolation of free fatty acids from other lipids fractions, free fatty acids profile were analyzed by gas chromatography system.
Results: Simvastatin increased the concentrations of medium chains free fatty acids such as hexanoic acid, octanoic acid, decanoic acid, undecanoic acid, and dodecanoic acid. Simvastatin also increased plasma total free fatty acids concentration.
Conclusion: The results of this study demonstrated that simvastatin by increasing the level of medium and long-chain free fatty acids can increase insulin secretion; on the other hand, simvastatin by increasing the level of total and saturated free fatty acids, could induce insulin resistance. More studies are necessary for the evaluation of the precise involved mechanisms in simvastatin effects on insulin function.


Guariguata L, Whiting DR, Hambleton I, Beagley J, Linnenkamp U, Shaw JE. Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract 2014; 103(2):137-49.
Esteves JV, Enguita FJ, Machado UF. MicroRNAs-Mediated Regulation of Skeletal Muscle GLUT4 Expression and Translocation in Insulin Resistance. J Diabetes Res 2017; 2017.
Esteghamati A, Etemad K, Koohpayehzadeh J, Abbasi M, Meysamie A, Noshad S, et al. Trends in the prevalence of diabetes and impaired fasting glucose in association with obesity in Iran: 2005-2011. Diabetes Res Clin Pract 2014; 103(2):319-27.
Fang P, Yu M, Guo L, Bo P, Zhang Z, Shi M. Galanin and its receptors: a novel strategy for appetite control and obesity therapy. Peptides 2012; 36(2):331-9.
Meshkani R, Adeli K. Hepatic insulin resistance, metabolic syndrome and cardiovascular disease. Clin Biochem 2009; 42(13-14):1331-46.
Han SH, Sakuma I, Shin EK, Koh KK. Antiatherosclerotic and Anti-Insulin Resistance Effects of Adiponectin: Basic and Clinical Studies. Prog Cardiovasc Dis 2009; 52(2):126-40.
Mohammadi A, Fallah H, Gholamhosseinian A. Antihyperglycemic Effect of Rosa Damascena is Mediated by PPAR.γGene Expression in Animal Model of Insulin Resistance. Iran J Pharm Res 2017; 16(3):1080-8.
Miyamoto J, Hasegawa S, Kasubuchi M, Ichimura A, Nakajima A, Kimura I. Nutritional Signaling via Free Fatty Acid Receptors. Int J Mol Sci 2016; 17(4):450.
9.   Meza-Cuenca F, Medina-Contreras JML, Mailloux-Salinas P, Bautista-Hernandez LA, Buentello-Volante B, Dominguez-Lopez A, et al. Characterization of free fatty acid receptors expression in an obesity rat model with high sucrose diet. J Recept Signal Transduct Res 2018; 38(1):76-82.
Miyamoto J, Kasubuchi M, Nakajima A, Kimura I. Anti-Inflammatory and Insulin-Sensitizing Effects of Free Fatty Acid Receptors. Handb Exp Pharmacol 2017; 236: 221-31.
Thirunavukkarasan M, Wang C, Rao A, Hind T, Teo YR, Siddiquee AA, et al. Short-chain fatty acid receptors inhibit invasive phenotypes in breast cancer cells. PLoS One 2017; 12(10):e0186334.
Kain V, Kapadia B, Misra P, Saxena U. Simvastatin may induce insulin resistance through a novel fatty acid mediated cholesterol independent mechanism. Sci Rep 2015; 5:13823.
Duvnjak L, Blaslov K. Statin treatment is associated with insulin sensitivity decrease in type 1 diabetes mellitus : A prospective, observational 56-month follow-up study. J Clin Lipidol 2016; 10(4):1004-10.
Mohammadi GA, Danesh B, Fallah H, Rahemi S. The Effect of Co-administration of Pioglitazone and Simvastatin on Insulin Resistance Parameters and PPAR.γ Expression in Insulin-resistant Rats. J Kerman Univ Med Sci 2017; 24(1):16-27.
CO K, DE K, JP D. New method for GC/FID and GC-C-IRMS analysis of plasma free fatty acid concentration and isotopic enrichment. J Chromatogr B Anal Technol Biomed Life Sci 2008; 873(1): 95-101.
Owens AP 3rd, Byrnes JR, Mackman N. Hyperlipidemia, tissue factor, coagulation, and simvastatin. Trends Cardiovasc Med 2014; 24(3):95-8.
Tunaru S, Bonnavion R, Brandenburger I, Preussner J, Thomas D, Scholich K, Offermanns S. 20-HETE promotes glucose-stimulated insulinsecretion in an autocrine manner through FFAR1. Nat Commun 2018; 9(1):177.
Welters HJ, Diakogiannaki E, Mordue JM, Tadayyon M, Smith SA, Morgan NG. Differential protective effects of palmitoleic acid and cAMP on caspase activation and cell viability in pancreatic cells exposed to palmitate. Apoptosis 2006; 11(7):1231-8.
Kristinsson H, Bergsten P, Sargsyan E. Free fatty acid receptor 1 (FFAR1/GPR40) signaling affects insulin secretion by enhancing mitochondrial respiration during palmitate exposure. Biochim Biophys Acta 2015; 1853(12): 3248-57.
Nøhr MK, Pedersen MH, Gille A, Egerod KL, Engelstoft MS, Husted AS, et al. GPR41/FFAR3 and GPR43/FFAR2 as Cosensors for Short-Chain Fatty Acids in Enteroendocrine Cells vs FFAR3 in Enteric Neurons and FFAR2 in Enteric Leukocytes. Endocrinology 2013; 154(10):3552-64.
Prentice KJ, Wheeler MB. FFAR out new targets for diabetes. Cell Metab 2015; 21(3):353-4.
Miller MR, Pereira RI, Langefeld CD, Lorenzo C, Rotter JI, Chen YD, Bergman RN, et al. Levels of Free Fatty Acids (FFA) Are Associated with Insulin Resistance But Do Not Explain the Relationship between Adiposity and Insulin Resistance in Hispanic Americans: The IRAS Family Study. J Clin Endocrinol Metab 2012; 97(9):3285-91.
Sears B, Perry M. The role of fatty acids in insulin resistance. Lipids Heal Dis 2015; 14:121.